Table 2.
Mean (standard deviation) and Repeated Measure Design of clinical scores during pre- and post-test intervention
| Groups | Repeated Measure ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Experimental Group | Waitlist Control | Group | Time | Group x Time | ηp2 | ||||||
|
Baseline M(SD) |
Post- Test M(SD) |
Baseline M(SD) |
Post- Test M(SD) |
F |
p- Value |
F | p-Value | F |
P- Value |
||
| PHQ-9 | 11.70(4.23) | 3.10(2.79) | 9.92(3.42) | 9.62(3.20) | 13.19 | .001 | 116.57 | .001 | 101.38 | .001 | .599 |
| PSS | 57.92(5.65) | 42.67(4.41) | 56.52(5.37) | 54.35(2.54) | 45.87 | .001 | 148.61 | .001 | 83.67 | .001 | .656 |
| DSS | 32.27(2.48) | 21.72(2.67) | 32.87(2.57) | 32.10(1.93) | 214.26 | .001 | 206.08 | .001 | 153.53 | .001 | .725 |
| NSI | 42.07(5.31) | 22.87(3.93) | 40.50(4.01) | 39.90(2.92) | 124.66 | .001 | 261.14 | .001 | 230.44 | .001 | .770 |
| PAS | 65.05(6.33) | 48.12(5.05) | 63.70(4.86) | 61.25(2.73) | 54.88 | .001 | 162.19 | .001 | 90.52 | .001 | .675 |
| HIVS | 128.50(9.12) | 87.32(8.28) | 126.85(9.22) | 123.52(6.27) | 171.90 | .001 | 288.11 | .001 | 208.42 | .001 | .787 |
| NAPA | 13.65(2.19) | 16.43(2.82) | 13.70(2.19) | 13.65(1.99) | 9.18 | .003 | 27.66 | .001 | 29.73 | .001 | .262 |
| NADP | 11.73(2.45) | 14.43(2.28) | 11.75(2.46) | 11.83(2.49) | 5.88 | .018 | 173.66 | .001 | 155.39 | .001 | .690 |
| GMAS | 25.38(3.06) | 30.85(3.78) | 25.45(2.96) | 25.47(3.02) | 16.56 | .001 | 78.79 | .001 | 77.36 | .001 | .503 |
| SOS | 4.31(1.57) | 6.58(.47) | 4.30(1.44) | 4.85(.89) | 19.12 | .001 | 66.71 | .001 | 24.87 | .001 | .461 |
| FAS | 2.76(1.20) | 5.71(1.20) | 3.00(1.25) | 2.55(1.12) | 45.19 | .001 | 63.50 | .001 | 117.44 | .001 | .449 |
| FRS | 2.66(1.38) | 5.10(1.68) | 2.44(1.16) | 2.21(.91) | 45.23 | .001 | 36.36 | .001 | 53.25 | .001 | .318 |
| MSSS | 3.25(.82) | 5.80(.74) | 3.25(.95) | 3.20(.67) | 87.30 | .001 | 119.83 | .001 | 128.33 | .001 | .606 |
| GHS | 5.72(1.28) | 9.00(.93) | 6.00(1.19) | 4.95(.87) | 88.26 | .001 | 66.65 | .001 | 251.83 | .001 | .461 |
| PHS | 14.00(1.47) | 17.85(1.28) | 14.36(1.77) | 13.18(1.08) | 76.92 | .001 | 150.22 | .001 | 71.11 | .001 | .658 |
| PSS | 13.30(1.86) | 17.62(1.70) | 13.96(1.98) | 12.30(1.28) | 79.14 | .001 | 110.28 | .001 | 21.82 | .001 | .586 |
| SRS | 12.05(1.66) | 18.35(1.74) | 11.65(1.74) | 10.30(1.39) | 222.11 | .001 | 265.77 | .001 | 111.27 | .001 | .773 |
| ESN | 14.85(1.36) | 17.38(1.09) | 15.31(1.55) | 13.66(1.14) | 51.99 | .001 | 128.40 | .001 | 5.73 | p001 | .662 |
| QOLB | 71.65(6.02) | 93.05(3.51) | 73.80(7.83) | 65.75(4.13) | 156.97 | .001 | 373.39 | .001 | 76.73 | .001 | .827 |
ηp2 Partial Squared Eta, PHQ Patient Health questionnaire, PSS Personalized Stigma Subscale, DSS Disclosure Subscale, NSI Negative Self Image, PAS Public Attitudes Subscale, HIVS HIV Stigma Scale, NAPA Non-adherence due to Patient Behavior, NADP Non-adherence due to Additional Disease and Pill Burden, GMAS General Medication Adherence Scale, SOS Significant other subscales, FAS Family Subscale, FRS Friends Subscale, MSSS Multidimensional Social Support Scale, GHS General Health Subscale, PHS Physical Health Subscale, PSS Psychological Subscale, SRS Social Relationship Subscale, ENS Environmental Subscale, QOLB Quality of Life Brief